Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood test may spot alcohol abuse in seniors better than current tools

NCT ID NCT02822911

Knowledge-focused Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a blood test called carbohydrate deficient transferrin (CDT) can better detect long-term alcohol abuse in people aged 60 and older compared to standard methods. Researchers enrolled 194 older adults in France and compared CDT results with a common questionnaire (AUDIT-C). The goal was to improve diagnosis in a group where alcohol problems are often missed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

194 people

The number who actually took part.

Start date

Mar 2016

Finished

Oct 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 60 years old * Patients hospitalized for a day or more in the Geriatrics Department of Mulhouse, GHRMSA : * Coming from home within 48 hours after admission to the GHRMSA * Study procedures performed within 72 hours after admission to the GHRMSA * Or new members of the General Practitioner Support Association of Alsace, France (translated in French as the "RAG") living in Mulhouse, Thann and Saint Louis cities (France) : * Living at home and joining the RAG between the 1st of March and the 31st of October 2016 * Study Procedures performed within 3 days after enrollment in the study * Relative or helper available who usually visits the patient at home at least once a week * Absence of alcoholic excipient in the concomitant medication Exclusion Criteria: * Age \< 60 years old * Admitted in the Geriatrics Department of Mulhouse after more than 48hours after admission to the GHRMSA * Presence of the following symptoms : * Hepatobiliary deficiency related to a primary biliary cirrhosis * Autoimmune or viral cirrhosis * Hepatocellular carcinoma * Congenital metabolic disorder in protein glycosylation * Known genetics variance in Tf B or D transferrin * Living in an elderly care institution * Already enrolled in this study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol abuse are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alcohol abuse disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol abuse

Contacts and locations

Locations

  • GHRMSA

    Mulhouse, 68100, France

  • Reseau d'Appui aux Generalistes (RAG)

    Colmar, 68000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.